clodronic acid has been researched along with Bone Fractures in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, A; Sinha, NK; Swe, KMM | 1 |
| Djulbegovic, B; Kumar, A; Mhaskar, R; Miladinovic, B | 1 |
| Chen, W; Huang, X; Jiang, H; Lin, R; Wu, C; Wu, J; Zhang, X; Zhu, B | 1 |
| Cavo, M; Dimopoulos, MA; Drake, MT; Durie, BG; García-Sanz, R; Jurczyszyn, A; Leleu, X; Lentzsch, S; Merlini, G; Morgan, G; Munshi, N; Raje, N; Rajkumar, SV; Reiman, T; Roodman, GD; Sezer, O; Shimizu, K; Spencer, A; Terpos, E; Turesson, I | 1 |
| Baraldi, E; Cremonesi, G; Frediani, B | 1 |
| Mészaros, Á; Veszelyné Kotán, E | 1 |
| Jalava, T; Johansson, H; Kanis, JA; Kayan, K; McCloskey, EV; Oden, A; Pande, K; Vasireddy, S | 1 |
| Kessenich, C | 1 |
| Ludwig, H; Zojer, N | 1 |
| Clark, OA; Djulbegovic, B; Glasmacher, A; Kumar, A; Mhaskar, R; Miladinovic, B; Redzepovic, J; Wheatley, K | 1 |
| Aiello, M; Campana, C; D'Armini, A; Goggi, C; Ippoliti, G; Pellegrini, C; Rinaldi, M; Viganò, M | 1 |
| Acciai, C; Baldi, F; Falsetti, P; Filippou, G; Frediani, B; Marcolongo, R | 1 |
| Alva, D; Cesareo, R; Contini, S; De Rosa, B; Iozzino, M; Lauria, A; Mallardo, L; Napolitano, C; Orsini, A; Reda, G | 1 |
| Clemens, MR; Fessele, K; Heim, ME | 1 |
| Kanis, JA | 1 |
| Ashley, S; Hanson, J; Kanis, JA; McCloskey, E; Paterson, AH; Powles, TJ | 1 |
| Ashley, S; Kanis, JA; McCloskey, EV; Paterson, AH; Powles, T | 1 |
| Licata, AA | 1 |
| Gennari, C; Reginster, JY | 1 |
| Bruce, NJ; Guest, JF; Kanis, JA; McCloskey, EV | 1 |
| Cocchi, D; Paganelli, C; Zaffe, D | 1 |
| Brion, N; Clerc, D; Paule, B | 1 |
| Cundy, T; Zacharin, M | 1 |
| Watts, NB | 1 |
12 review(s) available for clodronic acid and Bone Fractures
| Article | Year |
|---|---|
Treatment for osteoporosis in people with beta-thalassaemia.
Topics: Adult; Alendronate; beta-Thalassemia; Child; Clodronic Acid; Denosumab; Diphosphonates; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Pamidronate | 2023 |
Bisphosphonates in multiple myeloma: an updated network meta-analysis.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Diphosphonates; Disease-Free Survival; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Multiple Myeloma; Pamidronate; Randomized Controlled Trials as Topic; Spinal Fractures; Zoledronic Acid | 2017 |
Effect of bisphosphonates on overall survival in subgroups of patients with prostate cancer.
Topics: Bone Density; Bone Density Conservation Agents; Chemotherapy, Adjuvant; Clodronic Acid; Fractures, Bone; Humans; Male; Prostatic Neoplasms; Survival Rate; Zoledronic Acid | 2019 |
Effect of clodronate treatment on risk of fracture: a systematic review and meta-analysis.
Topics: Bone Density Conservation Agents; Clodronic Acid; Female; Fracture Healing; Fractures, Bone; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Probability; Prospective Studies; Randomized Controlled Trials as Topic | 2014 |
[Therapeutic practice of bisphosphonate use and related pharmaceutical issues I].
Topics: Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Hungary; Ibandronic Acid; Imidazoles; Osteoporosis; Pamidronate; Risedronic Acid; Zoledronic Acid | 2016 |
Supportive therapy in multiple myeloma.
Topics: Anemia; Blood Transfusion; Bone Diseases; Calcitonin; Clodronic Acid; Diphosphonates; Erythropoietin; Fractures, Bone; Hematinics; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteoporosis; Pamidronate; Recombinant Proteins; Renal Insufficiency; Zoledronic Acid | 2011 |
Bisphosphonates in multiple myeloma: a network meta-analysis.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Diphosphonates; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Multiple Myeloma; Pamidronate; Randomized Controlled Trials as Topic; Zoledronic Acid | 2012 |
Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
Topics: Alendronate; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Female; Fractures, Bone; Humans; Ibandronic Acid; Organometallic Compounds; Osteoporosis, Postmenopausal; Risedronic Acid; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D | 2007 |
Bone and cancer: pathophysiology and treatment of metastases.
Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Pain; Pamidronate; Parathyroid Hormone | 1995 |
Bisphosphonate therapy.
Topics: Alendronate; Animals; Bone Density; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid | 1997 |
Bisphosphonates and osteoporosis treatment in Italy.
Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Italy; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Safety | 1998 |
Treatment of osteoporosis with bisphosphonates.
Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid | 2001 |
5 trial(s) available for clodronic acid and Bone Fractures
| Article | Year |
|---|---|
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Algorithms; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Double-Blind Method; Female; Fractures, Bone; Hip Joint; Humans; Osteoporosis, Postmenopausal; Probability; Risk Assessment; Risk Factors; Treatment Outcome; United Kingdom | 2009 |
Clodronate treatment of established bone loss in cardiac recipients: a randomized study.
Topics: Adult; Aged; Antimetabolites; Bone Density; Bone Diseases, Metabolic; Clodronic Acid; Disease-Free Survival; Female; Fractures, Bone; Graft Survival; Heart Transplantation; Humans; Incidence; Male; Middle Aged; Postoperative Complications | 2003 |
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
Topics: Absorptiometry, Photon; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Bone Density; Calcium, Dietary; Clodronic Acid; Drug Administration Schedule; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis; Prednisone; Ultrasonography; Vitamin D | 2003 |
Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.
Topics: Adult; Aged; Analgesia; Bone Diseases; Bone Resorption; Calcium; Clodronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Osteoporosis; Prednisolone; Prospective Studies | 1993 |
Clodronate decreases the frequency of skeletal metastases in women with breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Disease-Free Survival; Double-Blind Method; Female; Fractures, Bone; Humans; Middle Aged; Survival Rate | 1996 |
7 other study(ies) available for clodronic acid and Bone Fractures
| Article | Year |
|---|---|
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
Topics: Administration, Intravenous; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Fractures, Bone; Humans; Imidazoles; International Cooperation; Magnetic Resonance Imaging; Medical Oncology; Multiple Myeloma; Osteonecrosis; Outcome Assessment, Health Care; Pamidronate; Positron-Emission Tomography; Practice Guidelines as Topic; Radiotherapy; Tomography, X-Ray Computed; Zoledronic Acid | 2013 |
Postmenopausal osteoporosis. The role of intravenous bisphosphonates.
Topics: Bone Density Conservation Agents; Clodronic Acid; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; United States | 2008 |
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Multiple Myeloma; Osteoporosis; Pain; Pamidronate | 1995 |
Economic impact of using clodronate in the management of patients with multiple myeloma.
Topics: Clodronic Acid; Cost-Benefit Analysis; Drug Costs; Fractures, Bone; Health Resources; Humans; Multiple Myeloma; Recurrence; Sensitivity and Specificity; Survival Analysis | 1999 |
Induction and pharmacological treatment of oral osteopenia in rats.
Topics: Animals; Bone Diseases, Metabolic; Clodronic Acid; Disease Models, Animal; Estradiol; Female; Fractures, Bone; Male; Mandibular Fractures; Maxillary Fractures; Osteoporosis; Placebos; Rats; Rats, Sprague-Dawley | 1999 |
[Biosphonates in oncology].
Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Neoplasms; Osteolysis; Pain; Pamidronate; Spinal Cord Compression | 2000 |
Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates.
Topics: Analgesics, Non-Narcotic; Bone Density; Child; Clodronic Acid; Diphosphonates; Female; Fractures, Bone; Growth; Humans; Infusions, Intravenous; Male; Osteoporosis; Pain; Pamidronate; Spine; Syndrome; Vision Disorders | 2000 |